Cyclosporine Inhalation Solution (CIS) ( DrugBank: Cyclosporine )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
228閉塞性細気管支炎3

228. 閉塞性細気管支炎


臨床試験数 : 97 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 156
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01273207
(ClinicalTrials.gov)
March 2, 20127/1/2011Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis ObliteransExtension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis ObliteransBronchiolitis Obliterans;Constructive Bronchiolitis;Graft Versus Host Disease;Bronchiolitis, Exudative;Bronchiolitis, Proliferative;Graft-Versus-Host DiseaseDrug: Cyclosporine Inhalation Solution (CIS)National Heart, Lung, and Blood Institute (NHLBI)NULLCompleted10 Years80 YearsAll7Phase 2United States
2NCT01287078
(ClinicalTrials.gov)
January 29, 201129/1/2011Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans SyndromePhase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans SyndromeConstrictive Bronchiolitis;Bronchiolitis Obliterans;Graft vs Host Disease;Bronchiolitis, Exudative;Bronchiolitis, ProliferativeDrug: Cyclosporine Inhalation SolutionNational Heart, Lung, and Blood Institute (NHLBI)NULLCompleted10 Years80 YearsAll25Phase 2United States
3NCT00755781
(ClinicalTrials.gov)
September 200817/9/2008Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung TransplantationA Multi-Center, Randomized, Controlled Study to Demonstrate the Efficacy and Safety of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung TransplantationLung TransplantDrug: Cyclosporine Inhalation Solution (CIS)APT Pharmaceuticals, Inc.NULLCompleted18 YearsN/ABoth284Phase 3United States;Canada